Bioglass and Bioactive Glasses and Their Impact on Healthcare

International Journal of Applied Glass Science

Volumn 7, Issue 4, 2016, Pages 423-434

  Jones, Julian R ^a   Brauer, Delia S ^b   Hupa, Leena ^c   Greenspan, David C ^d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c ÅBO AKADEMI UNIVERSITY   (Finland)

^d Spinode Consulting   (United States)

Author keywords

bioactive glass; bioglass; bone regeneration; synthetic bone grafts; wound healing

Indexed keywords

BIOMEDICAL EQUIPMENT; BONE; CERAMIC MATERIALS; CONSUMER PRODUCTS; HEALTH CARE; TISSUE REGENERATION;

BIOACTIVE CERAMIC; BONE REGENERATION; DISSOLUTION PRODUCTS; HEALTH CARE APPLICATION; MEDICAL DEVICES; REGULATORY BODIES; SYNTHETIC BONE GRAFTS; WOUND HEALING;

BIOACTIVE GLASS;

EID: 85006065016     PISSN: 20411286     EISSN: 20411294     Source Type: Journal    
DOI: 10.1111/ijag.12252     Document Type: Article

References (82)

1. L. L. Hench, “Opening Paper 2015 - Some Comments on Bioglass: Four Eras of Discovery and Development,” Biomed. Glasses, 1 [1] 1–11 (2015).
2. L. L. Hench, “The Story of Bioglass®,” J. Mater. Sci. Mater. Med., 17 [11] 967–978 (2006).
3. L. L. Hench, R. J. Splinter, W. C. Allen, and T. K. Greenlee, “Bonding Mechanisms at the Interface of Ceramic Prosthetic Materials,” J. Biomed. Mater. Res. Biomed. Mater. Symposium, 2 [1] 117–141 (1971).
4. T. Kokubo, “Bioactive Glass-Ceramics - Properties and Applications,” Biomaterials, 12 [2] 155–163 (1991).
5. R. Z. LeGeros, “Properties of Osteoconductive Biomaterials: Calcium Phosphates,” Clin. Orthop. Relat. Res., 395 81–98 (2002).
6. ASTM, F1538-03 Glass and Glass Ceramic Biomaterials for Implantation, 2009.
7. V. Miguez-Pacheco, L. L. Hench, and A. R. Boccaccini, “Bioactive Glasses Beyond Bone and Teeth: Emerging Applications in Contact With Soft Tissues,” Acta Biomater., 13 1–15 (2015).
8. H. Oonishi et al., “Comparative Bone Growth Behavior in Granules of Bioceramic Materials of Various Sizes,” J. Biomed. Mater. Res., 44 [1] 31–43 (1999).
9. H. Oonishi et al., “Particulate Bioglass Compared With Hydroxyapatite as a Bone Graft Substitute,” Clin. Orthop. Relat. Res., 334 316–325 (1997).
10. H. Oonishi et al., “Quantitative Comparison of Bone Growth Behavior in Granules of Bioglass (R), A-W Glass-Ceramic, and Hydroxyapatite,” J. Biomed. Mater. Res., 51 [1] 37–46 (2000).
11. D. L. Wheeler, E. J. Eschbach, R. G. Hoellrich, M. J. Montfort, and D. L. Chamberland, “Assessment of Resorbable Bioactive Material for Grafting of Critical-Size Cancellous Defects,” J. Orthop. Res., 18 [1] 140–148 (2000).
12. L. L. Hench and J. M. Polak, “Third-Generation Biomedical Materials,” Science, 295 [5557] 1014–1017 (2002).
13. I. A. Silver, J. Deas, and M. Erecinska, “Interactions of Bioactive Glasses With Osteoblasts in Vitro: Effects of 45S5 Bioglass (R), and 58S and 77S Bioactive Glasses on Metabolism, Intracellular ion Concentrations and Cell Viability,” Biomaterials, 22 [2] 175–185 (2001).
14. I. D. Xynos, A. J. Edgar, L. D. K. Buttery, L. L. Hench, and J. M. Polak, “Gene-Expression Profiling of Human Osteoblasts Following Treatment With the Ionic Products of Bioglass (R) 45S5 Dissolution,” J. Biomed. Mater. Res., 55 [2] 151–157 (2001).
15. I. D. Xynos, A. J. Edgar, L. D. K. Buttery, L. L. Hench, and J. M. Polak, “Ionic Products of Bioactive Glass Dissolution Increase Proliferation of Human Osteoblasts and Induce Insulin-Like Growth Factor II MRNA Expression and Protein Synthesis,” Biochem. Biophys. Res. Commun., 276 [2] 461–465 (2000).
16. I. D. Xynos, M. V. J. Hukkanen, J. J. Batten, L. D. Buttery, L. L. Hench, and J. M. Polak, “Bioglass 45S5 Stimulates Osteoblast Turnover and Enhances Bone Formation in Vitro: Implications and Applications for Bone Tissue Engineering,” Calcif. Tissue Int., 67 [4] 321–329 (2000).
17. L. L. Hench, “Genetic Design of Bioactive Glass,” J. Eur. Ceram. Soc., 29 [7] 1257–1265 (2009).
18. O. Tsigkou, J. R. Jones, J. M. Polak, and M. M. Stevens, “Differentiation of Fetal Osteoblasts and Formation of Mineralized Bone Nodules by 45S5 Bioglass (R) Conditioned Medium in the Absence of Osteogenic Supplements,” Biomaterials, 30 [21] 3542–3550 (2009).
19. A. Hoppe, N. S. Gueldal, and A. R. Boccaccini, “A Review of the Biological Response to Ionic Dissolution Products From Bioactive Glasses and Glass-Ceramics,” Biomaterials, 32 [11] 2757–2774 (2011).
20. M. N. Rahaman et al., “Bioactive Glass in Tissue Engineering,” Acta Biomater., 7 [6] 2355–2373 (2011).
21. S. B. Jung, D. E. Day, T. Day, W. Stoecker, and P. Taylor, “Treatment of non-Healing Diabetic Venous Stasis Ulcers With Bioactive Glass Nanofibers,” Wound Repair Regen., 19 [2] A30–A30 (2011).
22. E. A. Abou Neel, D. M. Pickup, S. P. Valappil, R. J. Newport, and J. C. Knowles, “Bioactive Functional Materials: A Perspective on Phosphate-Based Glasses,” J. Mater. Chem., 19 [6] 690–701 (2009).
23. T. Kucera, K. Urban, and S. Ragkou, “Healing of Cavitary Bone Defects,” Eur. J. Orthop. Surg. Traumatol., 22 [2] 123–128 (2012).
24. L. L. Hench, “Bioactive Materials for Gene Control;” New Materials and Technologies for Healthcare, eds., L. L. Hench, J. R. Jones, and M. B. Fenn. World Scientific, Singapore, 25–48, 2011.
25. K. R. Rust, G. T. Singleton, J. Wilson, and P. J. Antonelli, “Bioglass Middle ear Prosthesis: Long-Term Results,” Am. J. Otol., 17 [3] 371–374 (1996).
26. H. R. Stanley, M. B. Hall, A. E. Clark, C. J. King, L. L. Hench, and J. J. Berte, “Using 45S5 Bioglass Cones as Endosseous Ridge Maintenance Implants to Prevent Alveolar Ridge Resorption: A 5-Year Evaluation,” Int. J. Oral Maxillofac. Implants, 12 [1] 95–105 (1997).
27. S. B. Low, C. J. King, and J. Krieger, “An Evaluation of Bioactive Ceramic in the Treatment of Periodontal Osseous Defects,” Int. J. Periodontics. Restorative. Dent., 17 [4] 359–367 (1997).
28. T. B. Lovelace, J. T. Mellonig, R. M. Meffert, A. A. Jones, P. V. Nummikoski, and D. L. Cochran, “Clinical Evaluation of Bioactive Glass in the Treatment of Periodontal Osseous Defects in Humans,” J. Periodontol., 69 [9] 1027–1035 (1998).
29. E. S. Rosenberg, S. C. Cho, N. Elian, Z. N. Jalbout, S. Froum, and C. I. Evian, “A Comparison of Characteristics of Implant Failure and Survival in Periodontally Compromised and Periodontally Healthy Patients: A Clinical Report,” Int. J. Oral Maxillofac. Implants, 19 [6] 873–879 (2004).
30. C. R. Anderegg, D. C. Alexander, and M. Freidman, “A Bioactive Glass Particulate in the Treatment of Molar Furcation Invasions,” J. Periodontol., 70 [4] 384–387 (1999).
31. R. A. Yukna, G. H. Evans, M. B. Aichelmann-Reidy, and E. T. Mayer, “Clinical Comparison of Bioactive Glass Bone Replacement Graft Material and Expanded Polytetrafluoroethylene Barrier Membrane in Treating Human Mandibular Molar Class II Furcations,” J. Periodontol., 72 [2] 125–133 (2001).
32. J. S. Park, et al., “Effects of Pretreatment Clinical Parameters on Bioactive Glass Implantation in Intrabony Periodontal Defects,” J. Periodontol., 72 [6] 730–740 (2001).
33. M. R. Norton and J. Wilson, “Dental Implants Placed in Extraction Sites Implanted With Bioactive Glass: Human Histology and Clinical Outcome,” Int. J. Oral Maxillofac. Implants, 17 [2] 249–257 (2002).
34. A. Sculean, G. Barbe, G. C. Chiantella, N. B. Arweiler, M. Berakdar, and M. Brecx, “Clinical Evaluation of an Enamel Matrix Protein Derivative Combined With a Bioactive Glass for the Treatment of Intrabony Periodontal Defects in Humans,” J. Periodontol., 73 [4] 401–408 (2002).
35. R. Mengel, M. Soffner, and L. Flores-De-Jacoby, “Bioabsorbable Membrane and Bioactive Glass in the Treatment of Intrabony Defects in Patients With Generalized Aggressive Periodontitis: Results of a 12-Month Clinical and Radiological Study,” J. Periodontol., 74 [6] 899–908 (2003).
36. S. J. Froum, M. A. Weinberg, and D. Tarnow, “Comparison of Bioactive Glass Synthetic Bone Graft Particles and Open Debridement in the Treatment of Human Periodontal Defects. A Clinical Study,” J. Periodontol., 69 [6] 698–709 (1998).
37. C. A. Shapoff, D. C. Alexander, and A. E. Clark, “Clinical use of a Bioactive Glass Particulate in the Treatment of Human Osseous Defects,” Compend. Contin. Educ. Dent. (Jamesburg, NJ: 1995), 18 [4] 352–358 (1997).
38. J. S. Zamet et al., “Particulate Bioglass(R) as a Grafting Material in the Treatment of Periodontal Intrabony Defects,” J. Clin. Periodontol., 24 [6] 410–418 (1997).
39. J. S. Zamet, U. R. Darbar, G. S. Griffiths, W. Burgin, and H. N. Newman, “Particulate Bioglass (Perioglas(R)) in the Treatment of Periodontal Intrabony Defects,” J. Dent. Res., 76 2219–2219 (1997).
40. V. S. Yadav, S. C. Narula, R. K. Sharma, S. Tewari, and R. Yadav, “Clinical Evaluation of Guided Tissue Regeneration Combined With Autogenous Bone or Autogenous Bone Mixed With Bioactive Glass in Intrabony Defects,” J. Oral Sci., 53 [4] 481–488 (2011).
41. B. Ilharreborde et al., “Bioactive Glass as a Bone Substitute for Spinal Fusion in Adolescent Idiopathic Scoliosis a Comparative Study With Iliac Crest Autograft,” J. Pediatr. Orthop., 28 [3] 347–351 (2008).
42. E. J. G. Schepers and P. Ducheyne, “Bioactive Glass Particles of Narrow Size Range for the Treatment of Oral Bone Defects: A 1-24 Month Experiment With Several Materials and Particle Sizes and Size Ranges,” J. Oral Rehabil., 24 [3] 171–181 (1997).
43. E. Schepers, P. Ducheyne, L. Barbier, and S. Schepers, “Bioactive Glass Particles of Narrow Size Range: A new Material for the Repair of Bone Defects.,” Implant Dent., 2 [3] 151–156 (1993).
44. 3 System,” J. Mater. Sci. Mater. Med., 1 [4] 219–227 (1990).
45. P. Stoor, E. Soderling, and J. I. Salonen, “Antibacterial Effects of a Bioactive Glass Paste on Oral Microorganisms,” Acta Odontol. Scand., 56 [3] 161–165 (1998).
46. N. C. Lindfors, K. Tallroth, and A. J. Aho, “Bioactive Glass as Bone-Graft Substitute for Posterior Spinal Fusion in Rabbit,” J. Biomed. Mater. Res., 63 [2] 237–244 (2002).
47. J. T. Heikkila, H. J. Aho, A. Yliurpo, R. P. Happonen, and A. J. Aho, “Bone-Formation in Rabbit Cancellous Bone Defects Filled With Bioactive Glass Granules,” Acta Orthop. Scand., 66 [5] 463–467 (1995).
48. M. J. Peltola, K. M. J. Aitasalo, J. T. K. Suonpaa, A. Yli-Urpo, P. J. Laippala, and A. P. Forsback, “Frontal Sinus and Skull Bone Defect Obliteration With Three Synthetic Bioactive Materials. A Comparative Study,” J. Biomed. Mater. Res. Part B Appl. Biomater., 66B [1] 364–372 (2003).
49. N. C. Lindfors, I. Koski, J. T. Heikkila, K. Mattila, and A. J. Aho, “A Prospective Randomized 14-Year Follow-up Study of Bioactive Glass and Autogenous Bone as Bone Graft Substitutes in Benign Bone Tumors,” J. Biomed. Mater. Res. Part B Appl. Biomater., 94B [1] 157–164 (2010).
50. N. C. Lindfors, J. T. Heikkila, I. Koski, K. Mattila, and A. J. Aho, “Bioactive Glass and Autogenous Bone as Bone Graft Substitutes in Benign Bone Tumors,” J. Biomed. Mater. Res. Part B Appl. Biomater., 90B [1] 131–136 (2009).
51. N. C. Lindfors, J. T. Heikkila, and A. J. Aho, “Long-Term Evaluation of Blood Silicon and Ostecalcin in Operatively Treated Patients With Benign Bone Tumors Using Bioactive Glass and Autogenous Bone,” J. Biomed. Mater. Res. Part B Appl. Biomater., 87B [1] 73–76 (2008).
52. N. C. Lindfors, “Treatment of a Recurrent Aneurysmal Bone Cyst With Bioactive Glass in a Child Allows for Good Bone Remodelling and Growth,” Bone, 45 [2] 398–400 (2009).
53. K. Pernaa, et al., “Bioactive Glass S53P4 and Autograft Bone in Treatment of Depressed Tibial Plateau Fractures - A Prospective Randomized 11-Year Follow-up,” J. Long Term Eff. Med. Implants, 21 [2] 139–148 (2011).
54. J. T. Heikkila, J. Kukkonen, A. J. Aho, S. Moisander, T. Kyyronen, and K Mattila, “Bioactive Glass Granules: A Suitable Bone Substitute Material in the Operative Treatment of Depressed Lateral Tibial Plateau Fractures: A Prospective, Randomized 1 Year Follow-up Study,” J. Mater. Sci. Mater. Med., 22 [4] 1073–1080 (2011).
55. N. C. Lindfors et al., “Bioactive Glass S53P4 as Bone Graft Substitute in Treatment of Osteomyelitis,” Bone, 47 [2] 212–218 (2010).
56. J. Frantzen et al., “Instrumented Spondylodesis in Degenerative Spondylolisthesis With Bioactive Glass and Autologous Bone a Prospective 11-Year Follow-up,” J. Spinal Disord. Tech., 24 [7] 455–461 (2011).
57. T. Turunen, J. Peltola, A. Yli-Urpo, and R. P. Happonen, “Bioactive Glass Granules as a Bone Adjunctive Material in Maxillary Sinus Floor Augmentation,” Clin. Oral Implant Res., 15 [2] 135–141 (2004).
58. M. Peltola, K. Aitasalo, J. Suonpaa, M. Varpula, and A. Yli-Urpo, “Bioactive Glass S53P4 in Frontal Sinus Obliteration: A Long-Term Clinical Experience,” Head Neck, 28 [9] 834–841 (2006).
59. P. Stoor, J. Pulkkinen, and R. Grenman, “Bioactive Glass S53P4 in the Filling of Cavities in the Mastoid Cell Area in Surgery for Chronic Otitis Media,” Ann. Otol. Rhinol. Laryngol., 119 [6] 377–382 (2010).
60. L. Hupa, K. H. Karlsson, M. Hupa, and H. T. Aro, “Comparison of Bioactive Glasses in Vitro and in Vivo,” Glass Technol. Part A, 51 [2] 89–92 (2010).
61. Q. Z. Z. Chen, I. D. Thompson, and A. R. Boccaccini, “45S5 Bioglass-Derived Glass-Ceramic Scaffolds for Bone Tissue Engineering,” Biomaterials, 27 [11] 2414–2425 (2006).
62. O. Peitl, G. P. LaTorre, and L. L. Hench, “Effect of Crystallization on Apatite-Layer Formation of Bioactive Glass 45S5,” J. Biomed. Mater. Res., 30 [4] 509–514 (1996).
63. M. A. Schallenberger, K. Rossmeier, H. M. Lovick, T. R. Meyer, H. M. Aberman, and G. A. Juda, “Comparison of the Osteogenic Potential of OsteoSelect Demineralized Bone Matrix Putty to NovaBone Calcium- Phosphosilicate Synthetic Putty in a Cranial Defect Model,” J. Craniofac. Surg., 25 [2] 657–661 (2014).
64. Z. Wang, B. Lu, L. Chen, and J. A. Chang, “Evaluation of an Osteostimulative Putty in the Sheep Spine,” J. Mater. Sci. Mater. Med., 22 [1] 185–191 (2011).
65. J. F. Kirk, G. Ritter, C. Waters, S. Narisawa, J. L. Millan, and J. D. Talton, “Osteoconductivity and Osteoinductivity of NanoFUSE (R) DBM,” Cell Tissue Banking, 14 [1] 33–44 (2013).
66. J. R. Jones, “Review of Bioactive Glass: From Hench to Hybrids,” Acta Biomater., 9 [1] 4457–4486 (2013).
67. J. S. Rees and M. Addy, “A Cross-Sectional Study of Dentine Hypersensitivity,” J. Clin. Periodontol., 29 [11] 997–1003 (2002).
68. R. Orchardson and D. G. Gillam, “Managing Dentin Hypersensitivity,” J. Am. Dent. Assoc., 137 [7] 990–998 (2006).
69. D. G. Gillam, J. Y. Tang, N. J. Mordan, and H. N. Newman, “The Effects of a Novel Bioglass (R) Dentifrice on Dentine Sensitivity: A Scanning Electron Microscopy Investigation,” J. Oral Rehabil., 29 [4] 305–313 (2002).
70. A. R. Pradeep and A. Sharma, “Comparison of Clinical Efficacy of a Dentifrice Containing Calcium Sodium Phosphosilicate to a Dentifrice Containing Potassium Nitrate and to a Placebo on Dentinal Hypersensitivity: A Randomized Clinical Trial,” J. Periodontol., 81 [8] 1167–1173 (2010).
71. P. C. Lammers, I. M. P. M. Borggreven, F. C. M. Driessens, and I. W. E. van Dijk, “Influence of Fluoride and Carbonate on in Vitro Remineralization of Bovine Enamel,” J. Dent. Res., 70 970–974 (1991).
72. E. C. Moreno, M. Kresak, and R. T. Zahradnik, “Fluoridated Hydroxyapatite Solubility and Caries Formation,” Nature, 247 64–65 (1974).
73. J. D. B. Featherstone, “The Science and Practice of Caries Prevention,” J. Am. Dent. Assoc., 131 [7] 887–899 (2000).
74. M. Mneimne, R. G. Hill, A. J. Bushby, and D. S. Brauer, “High Phosphate Content Significantly Increases Apatite Formation of Fluoride-Containing Bioactive Glasses,” Acta Biomater., 7 [4] 1827–1834 (2011).
75. D. S. Brauer, M. Mneimne, and R. G. Hill, “Fluoride-Containing Bioactive Glasses: Fluoride Loss During Melting and ion Release in Tris Buffer Solution,” J. Non-Cryst. Solids, 357 [18] 3328–3333 (2011).
76. G. Lusvardi, G. Malavasi, L. Menabue, V. Aina, and C. Morterra, “Fluoride-Containing Bioactive Glasses: Surface Reactivity in Simulated Body Fluids Solutions,” Acta Biomater., 5 3548–3562 (2009).
77. D. S. Brauer, N. Karpukhina, M. D. O'Donnell, R. V. Law, and R. G. Hill, “Fluoride-Containing Bioactive Glasses: Effect of Glass Design and Structure on Degradation, pH and Apatite Formation in Simulated Body Fluid,” Acta Biomater., 6 3275–3282 (2010).
78. G. Lusvardi, G. Malavasi, L. Menabue, V. Aina, and C. Morterra, “Fluoride-Containing Bioactive Glasses: Surface Reactivity in Simulated Body Fluids Solutions,” Acta Biomater., 5 [9] 3548–3562 (2009).
79. M. Eden, “The Split Network Analysis for Exploring Composition-Structure Correlations in Multi-Component Glasses: I. Rationalizing Bioactivity-Composition Trends of Bioglasses,” J. Non-Cryst. Solids, 357 [6–7] 1595–1602 (2011).
80. R. Hill, D. Brauer, D. G. Gillam, N. Karpukhina, A. Bushby, and M. Mneime, inventors; Queen Mary and Westfield College, UK, assignee, Bioactive glass composition. WO patent WO 2011/161422 A1. 2011 29 December 2011.
81. ® Technology,” J. Clin. Dent., 22 2–67 (2011).
82. A. Banerjee, M. Hajatdoost-Sani, S. Farrell, and I. Thompson, “A Clinical Evaluation and Comparison of Bioactive Glass and Sodium Bicarbonate air-Polishing Powders,” J. Dent., 38 [6] 475–479 (2010).